BEAM - Beam Therapeutics Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Beam Therapeutics Inc.
IPO Date: February 6, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $2.54B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.53 | 3.68%
Avg Daily Range (30 D): $0.69 | 2.56%
Avg Daily Range (90 D): $0.93 | 3.13%
Institutional Daily Volume
Avg Daily Volume: 1.08M
Avg Daily Volume (30 D): 1.58M
Avg Daily Volume (90 D): 1.74M
Trade Size
Avg Trade Size (Sh.): 59
Avg Trade Size (Sh.) (30 D): 63
Avg Trade Size (Sh.) (90 D): 60
Institutional Trades
Total Institutional Trades: 4,204
Avg Institutional Trade: $2.99M
Avg Institutional Trade (30 D): $3.34M
Avg Institutional Trade (90 D): $3.42M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $5.15M
Avg Closing Trade (30 D): $6.27M
Avg Closing Trade (90 D): $7.91M
Avg Closing Volume: 153.96K
 
News
Sep 22, 2026 @ 1:06 PM
Cathie Wood Goes Bargain Hunting: 3 Stocks She Jus...
Source: Rick Munarriz
Aug 31, 2026 @ 11:00 AM
Beam Therapeutics to Participate in Upcoming Septe...
Source: Na
Aug 25, 2026 @ 12:57 PM
As Sickle Cell Innovation Accelerates, Hematologis...
Source: Spherix Global Insights
Jul 20, 2026 @ 5:30 PM
Cathie Wood Is Buying This Up-and-Coming Biotech S...
Source: Jeff Siegel
Jul 3, 2026 @ 8:44 AM
Gene Editing Therapeutics: Transforming Biopharmac...
Source: Researchandmarkets.Com
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.68 $-1.18 $-.91
Diluted EPS $-.68 $-1.18 $-.91
Revenue $156.04M $.49M $31.74M
Gross Profit
Net Income / Loss $-85.43M $-122.68M $-94.32M
Operating Income / Loss $-378.02M $-126.55M $-107.22M
Cost of Revenue
Net Cash Flow $-62.23M $-68.45M $-6.64M
PE Ratio